CYRX EBITDA | CRYOPORT, INC.

CRYOPORT, INC. (CYRX) EBITDA

2026-06-30: Basis Reported; EBITDA -$3.45M*; Operating income -$10.04M; Depreciation and amortization $6.59M*.
2026-03-31: Basis Reported; EBITDA -$3.21M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA -$3.68M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA -$3.52M*; Operating income -$9.93M; Depreciation and amortization $6.42M*.

Complete source-backed ebitda history.

Available history: 2010-06-30 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	-$3.45M*	-$10.04M	$6.59M*	$48.97M	-7.04%*	$9.10M*	$1.13M*	(m)	$4.85M	$28.01M	$505.00K
2026-03-31	Reported	-$3.21M	(m)	(m)	(m)	-6.72%	$9.98M	$3.73M	(m)	$3.91M	$27.62M	$108.00K
2025-12-31	Reported	-$3.68M	(m)	(m)	(m)	-8.09%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$3.52M*	-$9.93M	$6.42M*	$44.23M	-7.95%*	$3.45M*	$2.19M*	(m)	$4.52M	$26.73M	$165.00K
2025-06-30	Reported	-$2.35M*	-$9.65M	$7.30M*	$45.45M	-5.18%*	$4.35M*	-$7.34M*	(m)	$4.12M	$26.91M	$274.00K
2025-03-31	Reported	$452,000.00	(m)	(m)	(m)	1.10%	$3.17M	-$4.34M	(m)	$3.93M	$21.90M	$234.00K
2024-12-31	Reported	-$4.85M	(m)	(m)	(m)	-11.70%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	-$5.55M*	-$13.39M	$7.84M*	$38.32M	-14.49%*	$4.24M*	$447.00K*	(m)	$4.16M	$26.67M	$316.00K
2024-06-30	Reported	-$70.47M*	-$78.03M	$7.56M*	$39.71M	-177.47%*	$3.79M*	-$8.03M*	(m)	$4.65M	$27.24M	$66.00K
2024-03-31	Reported	-$10.04M	(m)	(m)	(m)	-26.92%	$4.01M	-$3.27M	(m)	$4.75M	$27.82M	$111.00K
2023-12-31	Reported	-$47.8M	(m)	(m)	(m)	651.88%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$10.00M*	-$16.91M	$6.91M*	(m)	(m)	$8.97M*	-$1.96M*	(m)	$5.15M	$36.02M	$471.00K
2023-06-30	Reported	-$11.61M*	-$18.33M	$6.72M*	(m)	(m)	$8.67M*	-$4.05M*	(m)	$4.26M	$38.80M	$635.00K
2023-03-31	Reported	-$3.64M	(m)	(m)	(m)	-5.80%	$9.57M	$2.77M	(m)	$3.88M	$33.24M	$492.00K
2022-12-31	Reported	-$4.9M	(m)	(m)	(m)	-8.12%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$2.02M*	-$7.80M	$5.79M*	(m)	(m)	$5.19M*	$982.00K*	(m)	$3.98M	$30.23M	$57.00K
2022-06-30	Reported	$233.00K*	-$5.25M	$5.48M*	(m)	(m)	$4.82M*	-$7.01M*	(m)	$3.52M	$30.56M	$364.00K
2022-03-31	Reported	-$2.45M	(m)	(m)	(m)	-4.69%	$4.25M	$524.00K	(m)	$3.54M	$26.62M	$341.00K
2021-12-31	Reported	-$3.06M	(m)	(m)	(m)	-5.42%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	$581.00K*	-$4.58M	$5.16M*	(m)	(m)	$8.85M*	$8.88M*	(m)	$4.19M	$23.90M	$1.02M
2021-06-30	Reported	$1.20M*	-$3.75M	$4.95M*	(m)	(m)	$3.89M*	$2.63M*	(m)	$4.46M	$24.69M	$499.00K
2021-03-31	Reported	$3.7M	(m)	(m)	(m)	6.93%	$2.81M	-$5.99M	(m)	$4.30M	$21.39M	$1.04M
2020-12-31	Reported	-$2.48M	(m)	(m)	(m)	-5.12%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$9.90M*	-$10.73M	$830.00K*	(m)	(m)	$2.58M*	-$4.84M*	(m)	$2.31M	$14.48M	-$29.00K
2020-06-30	Reported	-$5.00M*	-$5.84M	$845.00K*	(m)	(m)	$1.95M*	-$1.37M*	(m)	$1.95M	$9.03M	$50.00K
2020-03-31	Reported	-$2.76M	(m)	(m)	(m)	-28.26%	$596.00K	$1.06M	(m)	$1.73M	$7.11M	$33.00K
2019-12-31	Reported	-$53,477.00	(m)	(m)	(m)	-0.58%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$11.56M*	-$12.35M	$792.92K*	(m)	(m)	$1.61M*	-$813.39K*	(m)	$1.64M	(m)	$1.89K
2019-06-30	Reported	-$1.81M*	-$2.30M	$496.69K*	(m)	(m)	$1.46M*	-$1.06M*	(m)	$540.93K	(m)	$9.62K
2019-03-31	Reported	-$1.84M	(m)	(m)	(m)	-27.66%	$1.12M	-$189.60K	(m)	$489.60K	(m)	-$900.00
2018-12-31	Reported	-$1.96M	(m)	(m)	(m)	-34.36%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$1.95M*	-$2.16M	$214.00K*	(m)	(m)	$863.05K*	-$664.23K*	(m)	$463.36K	(m)	$2.10K
2018-06-30	Reported	-$2.27M*	-$2.46M	$191.36K*	(m)	(m)	$699.54K*	-$1.27M*	(m)	$448.59K	(m)	$12.82K
2018-03-31	Reported	-$1.61M	(m)	(m)	(m)	-40.03%	$269.54K	-$1.06M	(m)	$329.73K	(m)	$813.00
2017-12-31	Reported	-$2.1M	(m)	(m)	(m)	-63.16%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$1.80M*	-$1.99M	$184.07K*	(m)	(m)	$207.35K*	-$965.01K*	(m)	$344.80K	(m)	$0.00
2017-06-30	Reported	-$1.69M*	-$1.86M	$176.35K*	(m)	(m)	$391.24K*	-$568.17K*	(m)	$230.74K	(m)	$0.00
2017-03-31	Reported	-$1.64M	(m)	(m)	(m)	-60.38%	$631.08K	-$829.92K	(m)	$249.84K	(m)	$4.23K
2016-12-31	Reported	-$1.9M	(m)	(m)	(m)	-85.21%	$396.47K*	(m)	(m)	$103.15K*	(m)	$311.00*
2016-09-30	Reported	(m)	-$2.16M	(m)	(m)	(m)	(m)	(m)	(m)	$214.68K	(m)	$2.88K
2016-06-30	Reported	-$1.88M	(m)	(m)	(m)	-98.11%	$193.86K	(m)	(m)	$135.80K	(m)	$2.48K
2016-03-31	Reported	-$2.55M	(m)	(m)	(m)	-164.01%	$405.26K	(m)	(m)	$144.48K	(m)	$0.00
2015-12-31	Reported	-$2.61M*	-$2.68M	$72.30K*	(m)	(m)	$378.59K*	(m)	(m)	$227.76K	$2.84M	$305.00
2015-09-30	Reported	-$1.77M*	-$1.82M	$48.35K*	(m)	(m)	$225.79K*	(m)	(m)	$100.30K	$2.16M	$0.00
2015-06-30	Reported	-$1.57M	(m)	(m)	(m)	-109.74%	$109.61K	(m)	(m)	$77.72K	$2.03M	$3.32K
2015-03-31	Reported	-$1.65M	(m)	(m)	(m)	-137.69%	(m)	(m)	(m)	(m)	(m)	$1.60K
2014-12-31	Reported	-$1.31M*	-$1.36M	$50.04K*	(m)	(m)	$0.00*	(m)	(m)	$99.05K	$1.49M	$0.00
2014-09-30	Reported	-$1.32M*	-$1.38M	$50.05K*	(m)	(m)	$67.85K*	(m)	(m)	$89.28K	$1.51M	$0.00
2014-06-30	Reported	-$1.11M	(m)	(m)	(m)	-118.79%	$0.00	$917.00K	(m)	$79.24K	$1.43M	$1.60K
2014-03-31	Reported	-$1.22M	(m)	(m)	(m)	-146.28%	(m)	(m)	(m)	(m)	(m)	$1.60K
2013-12-31	Reported	-$1.18M*	-$1.26M	$79.20K*	(m)	(m)	$2.04K*	-$841.58K*	(m)	$118.49K	$1.31M	$0.00
2013-09-30	Reported	-$1.20M*	-$1.29M	$89.55K*	(m)	(m)	$6.24K*	-$1.15M*	(m)	$118.44K	$1.24M	$0.00
2013-06-30	Reported	-$1.17M	(m)	(m)	(m)	-239.90%	$131.26K	-$1.17M	(m)	$92.64K	$1.22M	$0.00
2013-03-31	Reported	-$1.59M	(m)	(m)	(m)	-432.68%	(m)	(m)	(m)	$120.00	$1.41K	(m)
2012-12-31	Reported	-$1.46M*	-$1.55M	$90.33K*	(m)	(m)	$24.39K*	-$1.02M*	(m)	$94.42K	$1.39M	$0.00
2012-09-30	Reported	-$1.43M*	-$1.55M	$121.90K*	(m)	(m)	$2.91K*	-$1.23M*	(m)	$101.66K	$1.34M	$1.60K
2012-06-30	Reported	-$1.45M	(m)	(m)	(m)	-755.63%	$43.87K	-$1.42M	(m)	$108.95K	$1.27M	$0.00
2012-03-31	Reported	-$1.38M	(m)	(m)	(m)	-779.36%	(m)	(m)	(m)	$145.00	$1.17K	(m)
2011-12-31	Reported	$86.62K*	-$2.06K	$88.69K*	(m)	(m)	$121.05K*	-$1.48M*	(m)	$121.00	$1.74K	$0.00*
2011-09-30	Reported	$81.22K*	-$1.94K	$83.16K*	(m)	(m)	$78.33K*	-$1.64M*	(m)	$125.00	$1.56K	$0.00*
2011-06-30	Reported	-$1.88M	(m)	(m)	(m)	-1520.14%	$44.48K	-$1.55M	(m)	$101.00	$1.63K	$1.60K
2011-03-31	Reported	-$1.39M	(m)	(m)	(m)	-1393.14%	(m)	(m)	(m)	(m)	(m)	(m)
2010-12-31	Reported	-$1.28M*	-$1.34M	$66.60K*	(m)	(m)	$27.99K*	-$1.41M*	(m)	$105.02K	$1.08M	$0.00*
2010-09-30	Reported	-$1.43M*	-$1.48M	$56.76K*	(m)	(m)	$60.23K*	-$985.03K*	(m)	$114.51K	$1.11M	$0.00*
2010-06-30	Reported	-$1.26M	(m)	(m)	(m)	-828.95%	$210.85K	-$1.25M	(m)	$122.12K	$943.26K	$1.60K

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$9.09M	(m)	(m)	(m)	-5.16%	$16.44M	-$8.58M	(m)	$17.04M	$102.82M	$1.80M
2024-12-31	Reported	-$90.91M	(m)	(m)	(m)	-57.99%	$17.25M	-$16.32M	(m)	$17.71M	$109.81M	$359.00K
2023-12-31	Reported	-$73.05M	(m)	(m)	(m)	-43.31%	$38.78M	-$757.00K	(m)	$18.04M	$108.26M	$345.00K
2023-09-30	Rolling	(m)	-$56.32M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-06-30	Rolling	(m)	-$47.22M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-03-31	Rolling	(m)	-$34.13M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-12-31	Reported	-$9.14M	(m)	(m)	(m)	-3.85%	$22.11M	-$1.85M	(m)	$15.72M	$120.06M	$2.24M
2022-12-31	Rolling	(m)	-$31.90M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Rolling	(m)	-$29.23M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-06-30	Rolling	(m)	-$26.00M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-03-31	Rolling	(m)	-$24.50M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-12-31	Reported	$2.42M	(m)	(m)	(m)	1.09%	$23.88M	$8.13M	(m)	$16.84M	$97.56M	$1.69M
2021-12-31	Rolling	(m)	-$17.83M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Rolling	(m)	-$19.31M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-06-30	Rolling	(m)	-$25.47M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-03-31	Rolling	(m)	-$27.57M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-12-31	Reported	-$20.14M	(m)	(m)	(m)	-25.59%	$8.92M	-$14.87M	(m)	$9.48M	$56.86M	-$45.00K
2020-12-31	Rolling	(m)	-$30.01M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Rolling	(m)	-$21.04M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	-$22.66M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	-$19.12M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	-$15.26M	(m)	(m)	(m)	-44.96%	$5.34M	-$1.32M	(m)	$3.74M	$31.29M	$62.00K
2019-12-31	Rolling	(m)	-$17.68M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	-$19.02M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Rolling	(m)	-$8.83M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	Rolling	(m)	-$8.99M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	Reported	-$7.79M	(m)	(m)	(m)	-39.67%	$2.91M	-$3.35M	(m)	$1.84M	(m)	$19.95K
2018-12-31	Rolling	(m)	-$8.64M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Rolling	(m)	-$8.70M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	-$8.52M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	-$7.92M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	Reported	-$7.23M	(m)	(m)	(m)	-60.46%	$1.71M	-$3.58M	(m)	$1.21M	(m)	$5.14K
2017-12-31	Rolling	(m)	-$7.89M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Rolling	-$7.03M*	-$7.62M*	$594.66K*	(m)	(m)	$1.63M*	(m)	(m)	$928.53K*	(m)	$4.54K*
2017-06-30	Rolling	(m)	-$7.80M*	(m)	(m)	(m)	(m)	(m)	(m)	$798.41K*	(m)	$7.42K*
2017-03-31	Rolling	(m)	-$7.91M*	(m)	(m)	(m)	(m)	(m)	(m)	$703.47K*	(m)	$9.90K*
2016-12-31	Reported	-$8.39M	(m)	(m)	(m)	-109.29%	$1.06M	-$5.72M	(m)	$598.11K	(m)	$5.67K
2016-12-31	Rolling	(m)	-$6.14M*	(m)	(m)	(m)	(m)	(m)	(m)	$598.11K*	(m)	$5.67K*
2016-09-30	Rolling	(m)	-$6.82M*	(m)	(m)	(m)	(m)	(m)	(m)	$722.72K*	(m)	$5.67K*
2016-06-30	Rolling	-$6.19M*	-$6.48M*	$291.40K*	(m)	(m)	$1.20M*	(m)	(m)	$608.34K*	(m)	$2.79K*
2016-03-31	Reported	-$8.5M	(m)	(m)	(m)	-144.53%	$1.12M	(m)	(m)	$550.26K	(m)	$3.63K
2016-03-31	Rolling	-$5.88M*	-$6.12M*	$239.23K*	(m)	(m)	$1.12M*	(m)	(m)	$550.26K*	(m)	$3.63K*
2015-12-31	Rolling	(m)	-$8.74M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$5.22K*
2015-09-30	Rolling	(m)	-$7.42M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$4.92K*
2015-06-30	Rolling	(m)	-$6.97M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$4.92K*
2015-03-31	Reported	-$5.4M	(m)	(m)	(m)	-137.09%	$70.13K	(m)	(m)	$352.58K	$6.41M	$1.60K
2015-03-31	Rolling	(m)	-$6.52M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$3.20K*
2014-12-31	Rolling	(m)	-$5.17M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$3.20K*
2014-09-30	Rolling	(m)	-$5.07M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$3.20K*
2014-06-30	Rolling	(m)	-$4.99M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$3.20K*
2014-03-31	Reported	-$4.77M	(m)	(m)	(m)	-179.21%	$138.89K	(m)	(m)	$409.11K	$5.11M	$1.60K
2014-03-31	Rolling	(m)	-$5.08M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$1.60K*
2013-12-31	Rolling	(m)	-$5.49M*	(m)	(m)	(m)	(m)	(m)	(m)	$329.69K*	$3.77M*	(m)
2013-09-30	Rolling	(m)	-$5.78M*	(m)	(m)	(m)	(m)	(m)	(m)	$305.62K*	$3.86M*	(m)
2013-06-30	Rolling	(m)	-$6.04M*	(m)	(m)	(m)	(m)	(m)	(m)	$288.84K*	$3.96M*	(m)
2013-03-31	Reported	-$5.93M	(m)	(m)	(m)	-538.87%	$156.20K	-$4.79M	(m)	$425.45K	$5.41M	$1.60K
2013-03-31	Rolling	(m)	-$6.33M*	(m)	(m)	(m)	(m)	(m)	(m)	$305.15K*	$4.00M*	(m)
2012-12-31	Rolling	(m)	-$4.65M*	(m)	(m)	(m)	(m)	(m)	(m)	$305.18K*	$4.00M*	(m)
2012-09-30	Rolling	(m)	-$3.10M*	(m)	(m)	(m)	(m)	(m)	(m)	$210.87K*	$2.61M*	(m)
2012-06-30	Rolling	(m)	-$1.55M*	(m)	(m)	(m)	(m)	(m)	(m)	$109.34K*	$1.27M*	(m)
2012-03-31	Reported	-$7.09M	(m)	(m)	(m)	-1276.31%	$262.64K	-$6.78M	(m)	$491.85K	$6.11M	$1.60K
2012-03-31	Rolling	(m)	-$7.43K*	(m)	(m)	(m)	(m)	(m)	(m)	$492.00*	$6.11K*	(m)
2011-03-31	Reported	-$5.35M	(m)	(m)	(m)	-1125.46%	$341.40K	-$4.81M	(m)	$449.13K	$4.32M	$1.60K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Theravance Biopharma, Inc. (TBPH)		$0.885B	16.40
RIGEL PHARMACEUTICALS INC (RIGL)	United States	$0.893B	2.25
Apnimed, Inc. (APMD)	United States	$0.899B
ARDELYX, INC. (ARDX)	United States	$0.857B	-22.86
Avalo Therapeutics, Inc. (AVTX)	United States	$0.842B	-9.74
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
Jade Biosciences, Inc. (JBIO)	United States	$0.936B	-9.21
LEXICON PHARMACEUTICALS, INC. (LXRX)	United States	$0.823B	-17.48
GYRE THERAPEUTICS, INC. (GYRE)	United States	$0.818B	-24.71